Sitemap

A list of all the posts and pages found on the site. For you robots out there, there is an XML version available for digesting as well.

Pages

Posts

portfolio

publications

A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder

A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder

Published in Frontiers in Psychiatry, 2025

This randomized pilot trial evaluates the safety, tolerability and clinical effects of hemp-derived cannabidiol in individuals with alcohol use disorder.

</article>
Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes

Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes

Published in Frontiers in Psychology Sec. Consciousness Research, 2025

This study links the aesthetic quality of retrospective self-reported psychedelic experiences to measures of perceived insight and psychological outcomes.

</article>
Neuroaesthetics of the psychedelic state

Neuroaesthetics of the psychedelic state

Published in Neuropsychologia, 2025

This paper outlines neural mechanisms underlying the aesthetic experience during psychedelic states and calls for direct research.

</article>
Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire

Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire

Published in Frontiers in Psychology Sec. Consciousness Research, 2025

This study refines and validates the Psychedelic Aesthetic Experience Questionnaire, a tool designed to measure the aesthetic qualities of psychedelic experiences.

</article>
Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use

Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use

Published in JAMA Psychiatry, 2025

This review synthesizes emerging data on psilocybin use trends, product variability, co-use with other substances, and adverse event reports. It highlights parallels with the cannabis legalization trajectory, showing that potency, product diversity, and unsupervised use are increasing while regulation and public education lag behind.

</article>

talks

teaching